Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

CME: 0.75

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review the latest evidence regarding the use of neoadjuvant treatment for patients with melanoma and the implications for clinical decision-making.
  • Evaluate patient and tumor characteristics that may help identify patients who may benefit from CPI-based adjuvant therapy based on the latest clinical evidence.
  • Examine the patient, tumor, and/or treatment characteristics that may help guide clinical decision-making for patients with recurrent melanoma.

Post a comment to this article